Search
Scientists Discover a Deadly Brain Cancer’s Hidden Weakness
The difficult-to-treat brain cancer glioblastoma steals a person’s mental faculties as it spreads, yet the tumor’s insidious ability to infiltrate distant networks in the brain could also prove its undoing.UCSF MD Link: Web-Based Communication Portal for Physicians
Our web portal allows referring physicians to securely access their patients’ entire electronic health record, make online referral requests and communicate with our physicians directly and securely.UCSF Study Finds 25% of Patients with HPV+ Oropharynx Cancer May Require Chemoradiotherapy After Robotic Surgery
In a nearly 10-year retrospective study involving 136 carefully selected patients with HPV-positive (HPV+) oropharynx cancer, UC San Francisco researchers found that one in four may meet possible indications for adjuvant chemoradiotherapy following transoral robotic surgery (TORS).Case Study: Multiple Myeloma and Novel Immunotherapy Approaches
Hematologist Nina Shah discusses the treatment plan of a patient diagnosed with a smoldering multiple myeloma (MM).A Concise Guide to Colorectal Cancer for Primary Care Providers
This presentation on colorectal cancer – the third most common cancer in the U.S. – unpacks the risk factors (including how to assess family history); reviews symptoms, treatments and survival data; and offers guidance on meeting patients’ post-treatment needs.Physician Survey Shows Lack of Understanding of the FDA’s Approval Process
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals are more rigorous than they are, according to a national survey of physicians conducted by researchers at UC San Francisco (UCSF).Salivary Gland Transfer for Head & Neck Cancer Patients
Discover the surprising way a simple surgery can vastly improve quality of life for head and neck cancer patients after radiation treatment. How? By moving the submandibular gland out of the way of the most intense radiation to prevent xerostomia.New Keys to Cancer Care: How 2023 Findings Impact Treatment Decisions
These four collaborative talks from UCSF and John Muir Health specialists shine a light on recent study results that should inform treatment planning for patients with a variety of GI, breast, lung and blood cancers.How AI Found the Words to Kill Cancer Cells
Predictive model allows researchers to encode commands for cells to carry out.Breast MRI and Advanced Breast Intervention
Bonnie Joe, MD, PhD, discusses how breast MRI is performed, common indications for breast MRI and advanced methods for biopsy and pre-surgical localization of tumors.Abortion Ban May Increase Risk of Death for Pregnant Women with Cancer
The repercussions of overturning Roe v. Wade – and the failure of the Supreme Court to provide any guidance on exceptions related to the life and health of the mother – are potentially catastrophic for a subset of women who face a life-threating diagnosis of pregnancy associated cancers (PAC).Precision Breast Cancer Trial Shows Improved Treatment by Tumor Subtype
Despite recent advances in the treatment of breast cancer, it remains the second leading cause of cancer death in the U.S. and worldwide.UCSF at the Forefront of New Therapies, Giving Hope to Multiple Myeloma Patients
Over the past few decades, advances in the treatment of multiple myeloma (MM) have accelerated at a thrilling pace, with a wealth of new therapeutic options now available for patients with this serious disease.Bladder Cancer Home Test Reduced Need for Cystoscopy During COVID-19
A study led by UCSF urologic cancer surgeons Sima Porten, MD, MPH, and Maxwell Meng, MD, found that use of a home urine test during the COVID-19 pandemic decreased the frequency of surveillance cystoscopy for patients with a history of non-muscle invasive bladder cancer (NMIBC).Head and Neck Surgical Oncology
Expert care to improve both survival and quality of lifeUpdates from the American Society of Clinical Oncology (ASCO) 2017
A June 2017 Bay Area Breast Cancer Forum discussion of updates from the ASCO annual meeting, covering PARP inhibitors, germline BRCA mutations, HER2-positive cancer, patient-reported outcomes, immunotherapy and more. Moderator: Dr. Hope RugoCan a New Drug Candidate Cure Pancreatic Cancer?
UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition.How This Cancer Drug Could Make Radiation a Slam Dunk Therapy
UCSF scientists combine a precision drug therapy with an antibody and radiation to eliminate tumors without causing side effects.UCSF Surgical Oncologists Providing New Treatment Options for Patients with Metastatic Gastrointestinal Cancers
UCSF Health’s surgical oncology team is a Bay Area leader in an innovative chemotherapy infusion pump used to treat patients with widely metastatic colorectal and bile duct cancers that have spread to the liver and are no longer considered operable.Screening for Cervical Cancer: New Evidence on Options and Outcomes
Gynecologic oncologist Megan Swanson, MD, MPH, deciphers recent changes to cervical cancer screening guidelines and uses the data to illuminate the relative value of test options – Pap smears, detection of high-risk HPV strains, or both tests together.International Hematologic Conference Features UCSF Health Experts
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 64th Annual Meeting and Exposition.Anal Cancer: A Primary Care Guide to Risks and Screening
Infectious disease specialist Cristina Brickman, MD, MSCE, explains how common anal cancer really is, which HPV types are associated, which patient populations should be screened and when to start – and when to refer to a specialist. Videos demonstrate proper technique for anal cytology collection and digital anorectal exams.Alan P. Venook, MD, Recognized With Luminary Award for Gastrointestinal Cancers
Alan P. Venook, MD, a renowned expert in colorectal and liver cancers, has been announced as one of the winners of the 2022 Luminary Awards in Gastrointestinal (GI) Cancers.Panel Issues First Guidelines to Prevent Anal Cancer in People With HIV
Results from a national study led by UC San Francisco informed the first guidelines at the federal level in the United States to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.